Speaker Profile
M.D., Ph.D., Co-founder and Chief Innovation Officer, Haystack Oncology
Biography
Joshua Cohen is a co-founder and the Chief Innovation Officer of Haystack Oncology. He is also conducts liquid biopsy research with Drs. Bert Vogelstein, Kenneth Kinzler, and Nickolas Papadopoulos at the Johns Hopkins Ludwig Center. Josh has invented and developed several liquid biopsy technologies, both for cancer screening and minimal residual disease detection, including the technology upon which Haystacks Duo chemistry is based. His liquid biopsy research served as the basis for a landmark prospective interventional clinical trial demonstrating, for the first time, the use of circulating tumor DNA analyses for the detection of minimal residual disease and selection of adjuvant chemotherapy in stage II colorectal cancer patients.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Adrian Lee, UPMC
- PMWC Award Ceremony
Pioneer Honoree: Victor Velculescu, Johns Hopkins
Luminary Honoree: Nicola Aceto, ETH Zurich
- Keynote: Early Detection of Cancer using Cell-free DNA Fragmentomes
- Victor Velculescu, Johns Hopkins - Keynote: The Power of a Blood Sample: Predictive Diagnostics and Transforming Healthcare
- Matthew Rabinowitz, Natera - Improving Sensitivity of MRD and MCED - Tumor-agnostic vs. Tumor-informed ctDNA Approaches
Chair: Adrian Lee, University of Pittsburgh
- Marija Balic, UPMC
- Ola Carl Landgren, University of Miami
- Carl Barrett, Precede Biosciences
- Jonathan Beer, BMS
- Innovative Approaches in Liquid Biopsy
Chair: Victor Velculescu, Johns Hopkins
- Adam Widman, MSKCC
- Brian Hashemi, Novigenix
- Sequencing Accuracy in Early Detection and MRD (PANEL)
Chair: Alex Sockell, PacBio
- James Hadfield, AstraZeneca
- Keynote: Keynote: Circulating Tumor Cells
- Nicola Aceto, ETH Zurich - Circulating Tumor Cells: The New Frontier
Chair: Nicola Aceto, ETH Zurich
- Min Yu, University of Maryland School of Medicine
- Matteo Ligorio, UTSW - Precision Liquid Biopsies: Innovations Across the Cancer Continuum – From Early Detection to Long-Term Monitoring
Chair: Tom Beer, Exact Sciences
- Elizabeth (Betsy) O’Donnell, Dana Farber Cancer Institute
- Arnaud Papin, Merck
- PMWC Showcase
- Wendy Winckler, Droplet Biosciences - Multi-Cancer Early Detection: Innovations and Real-World Evidence (PANEL)
Chair: Peter Bach, Delfi Dx
- Joshua Cohen, Haystack
- Lauren Leiman, BLOODPAC
- Eric Klein, Grail Bio
- Tom Beer, Exact Sciences - PMWC Showcase
- Varsha Rao, Claret Bio - PMWC Award Ceremony and Keynote
Luminary Honoree: Matthew Rabinowitz, Natera
